Trial Profile
A study to evaluate the effectiveness of sofosbuvir, ledipasvir/sofosbuvir and paritaprevir/ritonavir/ombitasvir and dasabuvir in hepatitis C patients in veterans affairs national healthcare system.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2018
Price :
$35
*
At a glance
- Drugs Dasabuvir (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Peginterferon (Primary) ; Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Feb 2017 New trial record